biomedicines Article Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System Silvia Cerantola 1,† , Valentina Caputi 1,2,†, Gabriella Contarini 3 , Maddalena Mereu 1, Antonella Bertazzo 1, Annalisa Bosi 4 , Davide Banfi 4, Dante Mantini 5,6 , Cristina Giaroni 4 and Maria Cecilia Giron 1,5,* 1 Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy;
[email protected] (S.C.);
[email protected] (V.C.);
[email protected] (M.M.);
[email protected] (A.B.) 2 Department of Poultry Science, University of Arkansas, Fayetteville, AR 72704, USA 3 Department of Biomedical and Biotechnological Sciences, University of Catania, 95131 Catania, Italy;
[email protected] 4 Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy;
[email protected] (A.B.); d.banfi
[email protected] (D.B.);
[email protected] (C.G.) 5 IRCCS San Camillo Hospital, 30126 Venice, Italy;
[email protected] or
[email protected] 6 Motor Control and Neuroplasticity Research Group, KU Leuven, 3000 Leuven, Belgium * Correspondence:
[email protected]; Tel.: +39-049-827-5091; Fax: +39-049-827-5093 † Authors contributed equally to this study. Abstract: Antidopaminergic gastrointestinal prokinetics are indeed commonly used to treat gas- trointestinal motility disorders, although the precise role of dopaminergic transmission in the gut is still unclear. Since dopamine transporter (DAT) is involved in several brain disorders by mod- Citation: Cerantola, S.; Caputi, V.; ulating extracellular dopamine in the central nervous system, this study evaluated the impact of Contarini, G.; Mereu, M.; Bertazzo, A.; DAT genetic reduction on the morpho-functional integrity of mouse small intestine enteric nervous Bosi, A.; Banfi, D.; Mantini, D.; system (ENS).